Geode Capital Management, LLC Xenon Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 68,809 shares of XENE stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,809
Previous 68,929 0.17%
Holding current value
$2.68 Million
Previous $2.69 Million 0.74%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$36.12 - $43.96 $4,334 - $5,275
-120 Reduced 0.17%
68,809 $2.71 Million
Q2 2024

Aug 09, 2024
BUY
$36.25 - $43.75 $170,375 - $205,625
4,700 Added 7.32%
68,929 $2.69 Million
Q1 2024

May 13, 2024
BUY
$42.66 - $50.04 $91,974 - $107,886
2,156 Added 3.47%
64,229 $2.77 Million
Q4 2023

Feb 13, 2024
BUY
$28.7 - $46.46 $175,873 - $284,706
6,128 Added 10.95%
62,073 $2.86 Million
Q3 2023

Nov 13, 2023
BUY
$34.16 - $39.73 $1,024 - $1,191
30 Added 0.05%
55,945 $1.91 Million
Q2 2023

Aug 11, 2023
BUY
$34.84 - $43.54 $6,619 - $8,272
190 Added 0.34%
55,915 $2.15 Million
Q1 2023

May 15, 2023
BUY
$33.46 - $40.35 $14,722 - $17,754
440 Added 0.8%
55,725 $1.99 Million
Q4 2022

Feb 13, 2023
SELL
$33.06 - $39.43 $216,146 - $257,793
-6,538 Reduced 10.58%
55,285 $2.18 Million
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $502,092 - $649,344
16,307 Added 35.83%
61,823 $2.23 Million
Q2 2022

Aug 12, 2022
BUY
$25.44 - $35.16 $440,569 - $608,900
17,318 Added 61.42%
45,516 $1.38 Million
Q4 2021

Feb 11, 2022
BUY
$15.6 - $35.4 $102,148 - $231,799
6,548 Added 30.24%
28,198 $880,000
Q2 2021

Aug 13, 2021
BUY
$16.81 - $20.0 $40,478 - $48,160
2,408 Added 12.51%
21,650 $403,000
Q2 2019

Aug 14, 2019
BUY
$8.51 - $10.75 $43,894 - $55,448
5,158 Added 36.62%
19,242 $189,000
Q4 2018

Feb 13, 2019
BUY
$5.61 - $12.62 $79,011 - $177,740
14,084 New
14,084 $88,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email